![](/img/cover-not-exists.png)
Safety of high-dose liposomal daunorubicin (daunoxome) for refractory or relapsed acute myeloblastic leukaemia
Athanasios Fassas, Regine Buffels, Panayotis Kaloyannidis, Achilles AnagnostopoulosVolume:
122
Year:
2003
Language:
english
Pages:
3
DOI:
10.1046/j.1365-2141.2003.04395_3.x
File:
PDF, 122 KB
english, 2003